Related Funds
Funds with similar focus
Fund Name | Location |
316 Investments | - |
C&B Capital | Atlanta, Georgia, United States |
Cedars Sinai Medical Center | California, Los Angeles, United States |
Climb Ventures | Geneva, Geneve, Switzerland |
Close Brothers | England, London, United Kingdom |
Converge Ventures | Hilliard, Ohio, United States |
Evergreen Pacific Partners | Seattle, United States, Washington |
GDA Group | - |
Goldin Ventures | Macungie, Pennsylvania, United States |
Ground Up Ventures | New York, New York, United States |
Heaven-Sent Capital Management | Beijing, Beijing, China |
Hong Kong Qibao International Group | China, Hong Kong, Hong Kong Island |
Life Science Fonds Esslingen | Baden-Württemberg, Esslingen, Germany |
LINICO Corporation | Carson City, Nevada, United States |
MEIF Proof-of-Concept & Early Stage Fund | - |
SIEGMUND Investment Company | Germany, Thuringen, Thuringia |
Strategic Global Investments | California, Carlsbad, United States |
Telindus | Camberley, Surrey, United Kingdom |
U.S. Environmental Protection Agency | District of Columbia, United States, Washington |
Western Union | Colorado, Englewood, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.